MedPath
FDA Approval

KETOROLAC TROMETHAMINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Henry Schein, Inc.
DUNS: 012430880
Effective Date
September 20, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Ketorolac(15 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

KETOROLAC TROMETHAMINE

Product Details

NDC Product Code
0404-9952
Application Number
ANDA204216
Marketing Category
ANDA (C73584)
Route of Administration
INTRAVENOUS, INTRAMUSCULAR
Effective Date
September 20, 2023
KetorolacActive
Code: 4EVE5946BQClass: ACTIBQuantity: 15 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
© Copyright 2025. All Rights Reserved by MedPath